SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Marie-Chantal Giroux, Raphael Santamaria, Pierre Hélie, Patrick Burns, Francis Beaudry, Pascal Vachon, Physiological, pharmacokinetic and liver metabolism comparisons between 3-, 6-, 12- and 18-month-old male Sprague Dawley rats under ketamine-xylazine anesthesia, Experimental Animals, 2016, 65, 1, 63

    CrossRef

  2. 2
    Masatoshi Maeki, Ashtamurthy S. Pawate, Kenichi Yamashita, Masahide Kawamoto, Manabu Tokeshi, Paul J. A. Kenis, Masaya Miyazaki, A Method of Cryoprotection for Protein Crystallography by Using a Microfluidic Chip and Its Application for in Situ X-ray Diffraction Measurements, Analytical Chemistry, 2015, 87, 8, 4194

    CrossRef

  3. 3
    Vinícius Gonçalves Maltarollo, Jadson Castro Gertrudes, Patrícia Rufino Oliveira, Kathia Maria Honorio, Applying machine learning techniques for ADME-Tox prediction: a review, Expert Opinion on Drug Metabolism & Toxicology, 2015, 11, 2, 259

    CrossRef

  4. 4
    Alberto Ruiz Orduna, Francis Beaudry, Characterization of endoproteolytic processing of dynorphins by proprotein convertases using mouse spinal cord S9 fractions and mass spectrometry, Neuropeptides, 2015,

    CrossRef

  5. 5
    James B.Y.H. Behrendorff, Weiliang Huang, Elizabeth M.J. Gillam, Directed evolution of cytochrome P450 enzymes for biocatalysis: exploiting the catalytic versatility of enzymes with relaxed substrate specificity, Biochemical Journal, 2015, 467, 1, 1

    CrossRef

  6. 6
    Jahan B. Ghasemi, Elmira Nazarshodeh, H. Abedi, Molecular docking, 2D and 3D-QSAR studies of new indole-based derivatives as HCV-NS5B polymerase inhibitors, Journal of the Iranian Chemical Society, 2015, 12, 10, 1789

    CrossRef

  7. 7
    K. Gokula Krishnan, R. Sivakumar, V. Thanikachalam, H. Saleem, M. Arockia doss, Synthesis, spectroscopic investigation and computational study of 3-(1-(((methoxycarbonyl)oxy)imino)ethyl)-2H-chromen-2-one, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2015, 144, 29

    CrossRef

  8. 8
    Susanne von Grafenstein, Julian E Fuchs, Markus M Huber, Andrea Bassi, Alessandra Lacetera, Veronika Ruzsanyi, Jakob Troppmair, Anton Amann, Klaus R Liedl, Precursors for cytochrome P450 profiling breath tests from anin silicoscreening approach, Journal of Breath Research, 2014, 8, 4, 046001

    CrossRef

  9. 9
    I.S. Chekman, O.O. Kazakova, A.O. Sirovaya, N.O. Gorchakova, V.V. Patsko, Purposeful Search and Constructing of New Medications (Rational Drug Design), Visnik Nacional'noi' akademii' nauk Ukrai'ni, 2014, 4, 48

    CrossRef

  10. 10
    Gisela Brändén, Tove Sjögren, Volker Schnecke, Yafeng Xue, Structure-based ligand design to overcome CYP inhibition in drug discovery projects, Drug Discovery Today, 2014, 19, 7, 905

    CrossRef

  11. 11
    Ryan Matsuda, Cong Bi, Jeanethe Anguizola, Matthew Sobansky, Elliott Rodriguez, John Vargas Badilla, Xiwei Zheng, Benjamin Hage, David S. Hage, Studies of metabolite–protein interactions: A review, Journal of Chromatography B, 2014, 966, 48

    CrossRef

  12. 12
    Virginie Y. Martiny, Maria A. Miteva, Advances in Molecular Modeling of Human Cytochrome P450 Polymorphism, Journal of Molecular Biology, 2013, 425, 21, 3978

    CrossRef

  13. 13
    Tatiana F. Gomes, Thais E.T. Pompeu, Daniel A. Rodrigues, François Noël, Ricardo Menegatti, Carolina H. Andrade, José R. Sabino, Eric S. Gil, Teresa Dalla Costa, Andresa H. Betti, Camila B. Antonio, Stela M.K. Rates, Carlos A.M. Fraga, Eliezer J. Barreiro, Valéria de Oliveira, Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound, European Journal of Medicinal Chemistry, 2013, 62, 214

    CrossRef

  14. 14
    Kevin P. Cusack, Hannes F. Koolman, Udo E.W. Lange, Hillary M. Peltier, Isabel Piel, Anil Vasudevan, Emerging technologies for metabolite generation and structural diversification, Bioorganic & Medicinal Chemistry Letters, 2013, 23, 20, 5471

    CrossRef

  15. 15
    Gabriele Cruciani, Massimo Baroni, Paolo Benedetti, Laura Goracci, Cosimo Gianluca Fortuna, Exposition and reactivity optimization to predict sites of metabolism in chemicals, Drug Discovery Today: Technologies, 2013, 10, 1, e155

    CrossRef

  16. 16
    Hajime Hirao, Pratanphorn Chuanprasit, Ying Yi Cheong, Xiaoqing Wang, How Is a Metabolic Intermediate Formed in the Mechanism-Based Inactivation of Cytochrome P450 by Using 1,1-Dimethylhydrazine: Hydrogen Abstraction or Nitrogen Oxidation?, Chemistry - A European Journal, 2013, 19, 23
  17. 17
    Mariana C. Sousa, Rodolpho C. Braga, Bertilha A.S. Cintra, Valéria de Oliveira, Carolina H. Andrade, In silico metabolism studies of dietary flavonoids by CYP1A2 and CYP2C9, Food Research International, 2013, 50, 1, 102

    CrossRef

  18. 18
    Nikhil Taxak, Sourav Kalra, Prasad V. Bharatam, Mechanism-Based Inactivation of Cytochromes by Furan Epoxide: Unraveling the Molecular Mechanism, Inorganic Chemistry, 2013, 52, 23, 13496

    CrossRef

  19. 19
    S. Gharaghani, T. Khayamian, M. Ebrahimi, Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors, SAR and QSAR in Environmental Research, 2013, 24, 9, 773

    CrossRef

  20. 20
    Przemyslaw Piechota, Mark T. D. Cronin, Mark Hewitt, Judith C. Madden, Pragmatic Approaches to Using Computational Methods To Predict Xenobiotic Metabolism, Journal of Chemical Information and Modeling, 2013, 53, 6, 1282

    CrossRef

  21. 21
    Jonathan D. Tyzack, Mark J. Williamson, Rubben Torella, Robert C. Glen, Prediction of Cytochrome P450 Xenobiotic Metabolism: Tethered Docking and Reactivity Derived from Ligand Molecular Orbital Analysis, Journal of Chemical Information and Modeling, 2013, 53, 6, 1294

    CrossRef

  22. 22
    James Matthew Hutzler, Ronald Scott Obach, Deepak Dalvie, Michael A Zientek, Strategies for a comprehensive understanding of metabolism by aldehyde oxidase, Expert Opinion on Drug Metabolism & Toxicology, 2013, 9, 2, 153

    CrossRef

  23. 23
    Hao Sun, Capture hydrolysis signals in the microsomal stability assay: Molecular mechanisms of the alkyl ester drug and prodrug metabolism, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 2, 989

    CrossRef

  24. 24
    Rodolpho C. Braga, Vinícius M. Alves, Carlos A. M. Fraga, Eliezer J. Barreiro, Valéria de Oliveira, Carolina H. Andrade, Combination of docking, molecular dynamics and quantum mechanical calculations for metabolism prediction of 3,4-methylenedioxybenzoyl-2-thienylhydrazone, Journal of Molecular Modeling, 2012, 18, 5, 2065

    CrossRef

  25. 25
    Johannes Kirchmair, Mark J. Williamson, Jonathan D. Tyzack, Lu Tan, Peter J. Bond, Andreas Bender, Robert C. Glen, Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms, Journal of Chemical Information and Modeling, 2012, 52, 3, 617

    CrossRef

  26. 26
    Kiumars Shahrokh, Thomas E. Cheatham, Garold S. Yost, Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen, Biochimica et Biophysica Acta (BBA) - General Subjects, 2012, 1820, 10, 1605

    CrossRef

  27. 27
    Valérie Campagna-Slater, Joshua Pottel, Eric Therrien, Louis-David Cantin, Nicolas Moitessier, Development of a Computational Tool to Rival Experts in the Prediction of Sites of Metabolism of Xenobiotics by P450s, Journal of Chemical Information and Modeling, 2012, 52, 9, 2471

    CrossRef

  28. 28
    Hao Sun, Andrew J. Bessire, Alfin Vaz, Dirlotapide as a model substrate to refine structure-based drug design strategies on CYP3A4-catalyzed metabolism, Bioorganic & Medicinal Chemistry Letters, 2012, 22, 1, 371

    CrossRef

  29. 29
    Sajjad Gharaghani, Taghi Khayamian, Fatemeh Keshavarz, Docking, molecular dynamics simulation studies, and structure-based QSAR model on cytochrome P450 2A6 inhibitors, Structural Chemistry, 2012, 23, 2, 341

    CrossRef

  30. 30
    Nicholas M. Njuguna, Collen Masimirembwa, Kelly Chibale, Identification and Characterization of Reactive Metabolites in Natural Products-Driven Drug Discovery, Journal of Natural Products, 2012, 75, 3, 507

    CrossRef

  31. 31
    Grace Xiaolu Yang, Xiyan Li, Michael Snyder, Investigating metabolite–protein interactions: An overview of available techniques, Methods, 2012, 57, 4, 459

    CrossRef

  32. 32
    Faizul Azam, Arwa M. Madi, Hamed I. Ali, Molecular Docking and Prediction of Pharmacokinetic Properties of Dual Mechanism Drugs that Block MAO-B and Adenosine A2A Receptors for the Treatment of Parkinson's Disease, Journal of Young Pharmacists, 2012, 4, 3, 184

    CrossRef

  33. 33
    Hajime Hirao, Zhi Hao Cheong, Xiaoqing Wang, Pivotal Role of Water in Terminating Enzymatic Function: A Density Functional Theory Study of the Mechanism-Based Inactivation of Cytochromes P450, The Journal of Physical Chemistry B, 2012, 116, 27, 7787

    CrossRef

  34. 34
    Chin Yee Liew, Chuen Pan, Andre Tan, Ke Xin Magneline Ang, Chun Wei Yap, QSAR classification of metabolic activation of chemicals into covalently reactive species, Molecular Diversity, 2012, 16, 2, 389

    CrossRef

  35. 35
    Kiumars Shahrokh, Anita Orendt, Garold S. Yost, Thomas E. Cheatham, Quantum mechanically derived AMBER-compatible heme parameters for various states of the cytochrome P450 catalytic cycle, Journal of Computational Chemistry, 2012, 33, 2
  36. 36
    Yin Cheong Wong, Shuai Qian, Zhong Zuo, Regioselective biotransformation of CNS drugs and its clinical impact on adverse drug reactions, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 7, 833

    CrossRef

  37. 37
    Kurt L.M. Drew, Jóhannes Reynisson, The impact of carbon–hydrogen bond dissociation energies on the prediction of the cytochrome P450 mediated major metabolic site of drug-like compounds, European Journal of Medicinal Chemistry, 2012, 56, 48

    CrossRef

  38. 38
    Peter Ballard, Patrick Brassil, Khanh H. Bui, Hugues Dolgos, Carl Petersson, Anders Tunek, Peter J. H. Webborn, The right compound in the right assay at the right time: an integrated discovery DMPK strategy, Drug Metabolism Reviews, 2012, 44, 3, 224

    CrossRef

  39. 39
    Gautier Moroy, Virginie Y. Martiny, Philippe Vayer, Bruno O. Villoutreix, Maria A. Miteva, Toward in silico structure-based ADMET prediction in drug discovery, Drug Discovery Today, 2012, 17, 1-2, 44

    CrossRef

  40. 40
    Alfonso T. García-Sosa, Sulev Sild, Kalev Takkis, Uko Maran, Combined Approach Using Ligand Efficiency, Cross-Docking, and Antitarget Hits for Wild-Type and Drug-Resistant Y181C HIV-1 Reverse Transcriptase, Journal of Chemical Information and Modeling, 2011, 51, 10, 2595

    CrossRef

  41. 41
    Hao Sun, Dennis O. Scott, Impact of genetic polymorphisms of cytochrome P450 2 C (CYP2C) enzymes on the drug metabolism and design of antidiabetics, Chemico-Biological Interactions, 2011, 194, 2-3, 159

    CrossRef

  42. 42
    Anton Yuryev, Integrating fragmented software applications into holistic solutions: focus on drug discovery, Expert Opinion on Drug Discovery, 2011, 6, 4, 383

    CrossRef

  43. 43
    Modest von Korff, Christian Rufener, Manuel Stritt, Joel Freyss, Roman Bär, Thomas Sander, Integration of distributed computing into the drug discovery process, Expert Opinion on Drug Discovery, 2011, 6, 2, 103

    CrossRef

  44. 44
    Hao Sun, Dennis O. Scott, Metabolism of 4-Aminopiperidine Drugs by Cytochrome P450s: Molecular and Quantum Mechanical Insights into Drug Design, ACS Medicinal Chemistry Letters, 2011, 2, 8, 638

    CrossRef

  45. 45
    Sorana Bolboacă, Lorentz Jäntschi, Predictivity Approach for Quantitative Structure-Property Models. Application for Blood-Brain Barrier Permeation of Diverse Drug-Like Compounds, International Journal of Molecular Sciences, 2011, 12, 12, 4348

    CrossRef

  46. 46
    Evan E Bolton, Jie Chen, Sunghwan Kim, Lianyi Han, Siqian He, Wenyao Shi, Vahan Simonyan, Yan Sun, Paul A Thiessen, Jiyao Wang, Bo Yu, Jian Zhang, Stephen H Bryant, PubChem3D: a new resource for scientists, Journal of Cheminformatics, 2011, 3, 1, 32

    CrossRef

  47. 47
    Chao Xu, Donald E Mager, Quantitative structure–pharmacokinetic relationships, Expert Opinion on Drug Metabolism & Toxicology, 2011, 7, 1, 63

    CrossRef

  48. 48
    Arthur N. Mayeno, Jonathan L. Robinson, Brad Reisfeld, Rapid estimation of activation enthalpies for cytochrome-P450-mediated hydroxylations, Journal of Computational Chemistry, 2011, 32, 4
  49. 49
    Leposava Antonovic, Marilyn Martinez, Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going?, Future Medicinal Chemistry, 2011, 3, 7, 855

    CrossRef

  50. 50
    Bernd Wendt, Marcel Mülbaier, Sabine Wawro, Christoph Schultes, Jorge Alonso, Bernd Janssen, Joe Lewis, Toluidinesulfonamide Hypoxia-Induced Factor 1 Inhibitors: Alleviating Drug–Drug Interactions through Use of PubChem Data and Comparative Molecular Field Analysis Guided Synthesis, Journal of Medicinal Chemistry, 2011, 54, 11, 3982

    CrossRef

  51. 51
    Hua Gao, Stefanus J Steyn, George Chang, Jing Lin, Assessment ofin silicomodels for fraction of unbound drug in human liver microsomes, Expert Opinion on Drug Metabolism & Toxicology, 2010, 6, 5, 533

    CrossRef

  52. 52
    Lucas Donovan, Scott M. Welford, John Haaga, Joseph LaManna, Kingman P. Strohl, Hypoxia—implications for pharmaceutical developments, Sleep and Breathing, 2010, 14, 4, 291

    CrossRef

  53. 53
    Emmanuel O. Carneiro, Carolina H. Andrade, Rodolpho C. Braga, Andréa C.B. Tôrres, Rosângela O. Alves, Luciano M. Lião, Carlos A.M. Fraga, Eliezer J. Barreiro, Valéria de Oliveira, Structure-based prediction and biosynthesis of the major mammalian metabolite of the cardioactive prototype LASSBio-294, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 12, 3734

    CrossRef

  54. 54
    Virginie Y. Martiny, Ilza Pajeva, Michael Wiese, Andrew M. Davis, Maria A. Miteva, Chemoinformatic and Chemogenomic Approach to ADMET,
  55. 55
    Nigel J. Waters, Michelle K. Dennehy, Computational Approaches in Drug Biotransformation Studies: Metabolite Prediction, Handbook of Metabolic Pathways of Xenobiotics,
  56. 56
    Imtiaz M. Shah, Catherine J. Breslin, Simon P. Mackay, Cytochrome P450 Pharmacogenetics: From Bench to bedside,
  57. 57
    W. Griffith Humphreys, Drug Metabolism Research as Integral Part of Drug Discovery and Development Processes,
  58. 58
    W. Griffith Humphreys, In Vivo Experimental Models for Studying Drug Biotransformation, Handbook of Metabolic Pathways of Xenobiotics,
  59. 59
    Kevin Beaumont, James R. Gosset, Chris E. Keefer, Integrated Assessment of Drug Clearance and Cross-Species Scalability,
  60. 60
    W. Griffith Humphreys, Pharmacological and Toxicological Activity of Drug Metabolites,
  61. 61
    Rodolpho C. Braga, Vinicius M. Alves, Flavia C. Silva, Carolina H. Andrade, QSAR and Molecular Modeling Approaches for Prediction of Drug Metabolism, Encyclopedia of Drug Metabolism and Interactions,